0001209191-23-052586.txt : 20231010 0001209191-23-052586.hdr.sgml : 20231010 20231010214929 ACCESSION NUMBER: 0001209191-23-052586 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231006 FILED AS OF DATE: 20231010 DATE AS OF CHANGE: 20231010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHAH BIMAL R. CENTRAL INDEX KEY: 0001557394 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40388 FILM NUMBER: 231319330 MAIL ADDRESS: STREET 1: C/O SPECTRUM PHARMACEUTICALS STREET 2: 11500 SOUTH EASTER AVENUE, SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815974 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851170950 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 BUSINESS PHONE: 737 203 5270 MAIL ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-06 0 0001815974 Anebulo Pharmaceuticals, Inc. ANEB 0001557394 SHAH BIMAL R. C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, STE. 107 LAKEWAY TX 78734 1 0 0 0 0 Stock Option (right to buy) 3.0271 2023-10-06 4 A 0 26097 0.00 A 2033-10-05 Common Stock 26097 26097 D 25% of the original number of shares vest on the first anniversary of October 6, 2023 (the "Vesting Commencement Date") and 2.0833% of the original number of shares vest at the end of each successive month following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date. /s/ Bimal Shah 2023-10-10